BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 7799165)

  • 1. Mechanism of lysis of Trypanosoma brucei gambiense by human serum.
    Ortiz-Ordóñez JC; Sechelski JB; Seed JR
    J Parasitol; 1994 Dec; 80(6):924-30. PubMed ID: 7799165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The removal of trypanolytic activity from human serum by Trypanosoma brucei gambiense and its subsequent recovery in trypanosome lysates.
    Ortiz-Ordóñez JC; Seed JR
    J Parasitol; 1995 Aug; 81(4):555-8. PubMed ID: 7623196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of human serum-resistant and serum-sensitive clones from a single Trypanosoma brucei gambiense parental clone.
    Ortiz JC; Sechelski JB; Seed JR
    J Parasitol; 1994 Aug; 80(4):550-7. PubMed ID: 8064522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmentally regulated sensitivity of Trypanosoma brucei brucei to the cytotoxic effects of human high-density lipoprotein.
    Moore DR; Smith A; Hager KM; Waldon R; Esko JD; Hajduk SL
    Exp Parasitol; 1995 Sep; 81(2):216-26. PubMed ID: 7556564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of high-density lipoprotein with Trypanosoma brucei: effect of membrane stabilizers.
    Rifkin MR
    J Cell Biochem; 1983; 23(1-4):57-70. PubMed ID: 6327740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of resistance of African trypanosomes to cytotoxic human HDL.
    Hager KM; Hajduk SL
    Nature; 1997 Feb; 385(6619):823-6. PubMed ID: 9039915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a tryptophan-like epitope borne by the variable surface glycoprotein (VSG) of African trypanosomes.
    Semballa S; Okomo-Assoumou MC; Holzmuller P; Büscher P; Magez S; Lemesre JL; Daulouede S; Courtois P; Geffard M; Vincendeau P
    Exp Parasitol; 2007 Feb; 115(2):173-80. PubMed ID: 17014849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The trypanolytic factor of human serum.
    Pays E; Vanhollebeke B; Vanhamme L; Paturiaux-Hanocq F; Nolan DP; Pérez-Morga D
    Nat Rev Microbiol; 2006 Jun; 4(6):477-86. PubMed ID: 16710327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A co-evolutionary arms race: trypanosomes shaping the human genome, humans shaping the trypanosome genome.
    Capewell P; Cooper A; Clucas C; Weir W; Macleod A
    Parasitology; 2015 Feb; 142 Suppl 1(Suppl 1):S108-19. PubMed ID: 25656360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypanosoma brucei sspp.: cleavage of variant specific and common glycoproteins during exposure of live cells to trypsin.
    Frommel TO; Seyfang A; Balber AE
    Exp Parasitol; 1988 Aug; 66(2):213-24. PubMed ID: 2456221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Human African trypanosomiasis].
    Dumas M; Bouteille B
    C R Seances Soc Biol Fil; 1996; 190(4):395-408. PubMed ID: 8952890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trypanosoma brucei: immunogenicity of the variant surface coat glycoprotein of virulent and avirulent subspecies.
    Diffley P
    Exp Parasitol; 1985 Feb; 59(1):98-107. PubMed ID: 3967729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutual self-defence: the trypanolytic factor story.
    Pays E; Vanhollebeke B
    Microbes Infect; 2008 Jul; 10(9):985-9. PubMed ID: 18675374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of metacyclic forms by cyclical transmission of west African Trypanosoma (T.) brucei isolates from man and animals.
    Richner D; Brun R; Jenni L
    Acta Trop; 1988 Dec; 45(4):309-19. PubMed ID: 2467539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences between Trypanosoma brucei gambiense groups 1 and 2 in their resistance to killing by trypanolytic factor 1.
    Capewell P; Veitch NJ; Turner CM; Raper J; Berriman M; Hajduk SL; MacLeod A
    PLoS Negl Trop Dis; 2011 Sep; 5(9):e1287. PubMed ID: 21909441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOL1 expression is induced by Trypanosoma brucei gambiense infection but is not associated with differential susceptibility to sleeping sickness.
    Ilboudo H; Berthier D; Camara M; Camara O; Kabore J; Leno M; Keletigui S; Chantal I; Jamonneau V; Belem AM; Cuny G; Bucheton B
    Infect Genet Evol; 2012 Oct; 12(7):1519-23. PubMed ID: 22691369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Trypanolytic factor of human serum].
    Perez-Morga D
    Bull Mem Acad R Med Belg; 2006; 161(5):309-15. PubMed ID: 17283903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Trypanosoma brucei bloodstream form mutant deficient in ornithine decarboxylase can protect against wild-type infection in mice.
    Mutomba MC; Li F; Gottesdiener KM; Wang CC
    Exp Parasitol; 1999 Feb; 91(2):176-84. PubMed ID: 9990346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of Trypanosoma brucei gambiense resistance to human serum.
    Uzureau P; Uzureau S; Lecordier L; Fontaine F; Tebabi P; Homblé F; Grélard A; Zhendre V; Nolan DP; Lins L; Crowet JM; Pays A; Felu C; Poelvoorde P; Vanhollebeke B; Moestrup SK; Lyngsø J; Pedersen JS; Mottram JC; Dufourc EJ; Pérez-Morga D; Pays E
    Nature; 2013 Sep; 501(7467):430-4. PubMed ID: 23965626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of expression site switching in the development of resistance to human Trypanosome Lytic Factor-1 in Trypanosoma brucei brucei.
    Kieft R; Stephens NA; Capewell P; MacLeod A; Hajduk SL
    Mol Biochem Parasitol; 2012 May; 183(1):8-14. PubMed ID: 22226682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.